Image via Wikipedia
After discontinuing long-term hormone therapy, postmenopausal women should have their bone mineral density monitored and should start bone-preserving therapy if necessary, according to the North American Menopause Society.
The guidance is included in a position statement that updates a statement the society issued in 2008.
The new statement, crafted by an advisory panel led by Wulf Utian, MD, PhD, of Case Western Reserve University in Cleveland, was published in the March/April issue of Menopause.
Continue Reading
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_b.png?x-id=dba25017-70a4-42ca-be75-8999f450745c)
No comments:
Post a Comment